Skip to content

Effects of target - controlled infusion of sufentanil combined with sevoflurane general anesthesia on perioperative stress response

Effects of target - controlled infusion of sufentanil combined with sevoflurane general anesthesia on perioperative stress response

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15006810
Enrollment
Unknown
Registered
2015-07-25
Start date
2015-08-02
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia of laparoscopic surgery

Interventions

Group S1:Anesthesia is maintained with sufentanil TCI (at low concentration) and sevoflurane
Group S2:Anesthesia is maintained with sufentanil TCI (at common concentration) and sevoflurane

Sponsors

Department of Anesthesiology, Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 68 Years

Inclusion criteria

Inclusion criteria: Forty patients with American Society of Anesthesiologists (ASA) I or II, scheduled for elective laparoscopic surgery under general anesthesia, all genders, aged 18-68 years, body mass index less than 30 kg/m2, with normal hepatic or renal function, without uncontrolled hypertension and/or diabetes mellitus, severe heart and lung diseases, a history of long term use of opioids, and signed informed consent form before anesthesa, will be prospectively studied.

Exclusion criteria

Exclusion criteria: Patients with ASA III or above, body mass index more than (or equal to) 30 kg/m2, with a history of adverse reaction to opioids or (family) history of malignant hyperthermia, participated in similar studies in the last six months, received preoperative opioids, having drug and alcohol dependency, refused to sign an informed consent form, or total time of target-controlled infusion of sufentanil is more than 4 hours, will be excluded.

Design outcomes

Primary

MeasureTime frame
Blood adrenaline concentration;Blood noradrenaline concentration;Blood dopamine concentration;Blood cortisol concentration;Blood glucose concentration;Hemodynamic changes;

Countries

China

Contacts

Public ContactYan Zhao
zhaoyan2004@263.net+86 13911666385

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026